Home › Funds › Parametrica Management Ltd › FATE

Parametrica Management Ltd position in FATE

FATE THERAPEUTICS INC · Health Care

Parametrica Management Ltd reported holding 18,472 shares of FATE (FATE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$44K, representing 0.04% of its reported portfolio and ranking #26 among its reported holdings. Parametrica Management Ltd has disclosed FATE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.47K sh
Reported value held$43.78K
Portfolio Weight0.04%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Parametrica Management Ltd's FATE position evolved

Parametrica Management Ltd first disclosed a stake in FATE in Q3 2023 at 18,472 shares (US$39K). The position peaked in Q1 2024 at 18,472 shares, worth US$136K. Across 13 filings, Parametrica Management Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 18,472 shares valued at US$44K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.47K $39.16K New
Q4 2023 18.47K $69.08K Hold
Q1 2024 18.47K $135.58K Hold
Q2 2024 18.47K $60.59K Hold
Q3 2024 18.47K $64.65K Hold
Q4 2024 18.47K $30.48K Hold
Q1 2025 18.47K $14.60K Hold
Q2 2025 18.47K $20.69K Hold
Q3 2025 18.47K $23.27K Hold
Q4 2025 18.47K $18.15K Hold
Q1 2026 18.47K $22.17K Hold
Q2 2026 18.47K $49.87K Hold
Q3 2026 18.47K $43.78K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FATE and 13F data

FATE (FATE THERAPEUTICS INC) is a Health Care company. 19 other funds we track also report a position in FATE — the largest reported positions include Redmile Group, LLC (US$34.8M), JOHNSON & JOHNSON (US$8.0M), Bruce & Co., Inc. (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FATE

All FATE fund holders →

FAQ

How long has Parametrica Management Ltd held FATE?

Parametrica Management Ltd has disclosed FATE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Parametrica Management Ltd's current position in FATE?

As of Q3 2026, Parametrica Management Ltd holds 18.47K shares of FATE (FATE THERAPEUTICS INC), valued at $43.78K, representing 0.04% of its reported portfolio and ranking #26.

Has Parametrica Management Ltd been buying or selling FATE?

In the latest 13F filing (Q3 2026), Parametrica Management Ltd held unchanged its position in FATE. The position peaked in Q1 2024 at 18.47K shares.

Which other funds hold FATE?

Other major institutional holders of FATE include Redmile Group, LLC, JOHNSON & JOHNSON, Bruce & Co., Inc., among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.